Share Price and Basic Stock Data
Last Updated: January 22, 2026, 8:24 pm
| PEG Ratio | 0.59 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Fluidomat Ltd operates in the engineering sector, focusing on delivering high-quality products and services. The company reported a market capitalization of ₹330 Cr and a current price of ₹669 per share. Over the past few years, Fluidomat has demonstrated robust revenue growth, with sales rising from ₹33 Cr in FY 2022 to ₹45 Cr in FY 2023, and further projected to reach ₹55 Cr in FY 2024 and ₹71 Cr in FY 2025. This upward trajectory reflects a compound annual growth rate (CAGR) of approximately 27% from FY 2022 to FY 2025. Quarterly sales figures reveal a consistent performance, with the latest figure for September 2023 standing at ₹14.65 Cr, indicating a solid recovery from the prior quarter’s ₹12.56 Cr. The company’s ability to maintain sales growth amidst fluctuating market conditions underscores its competitive positioning within the engineering domain.
Profitability and Efficiency Metrics
Fluidomat Ltd has reported impressive profitability metrics, with a net profit of ₹19 Cr for FY 2023, translating to a net profit margin of 22.22%. The operating profit margin (OPM) for the same period stood at 30.73%, highlighting the company’s effective cost management strategies. The return on equity (ROE) at 31.4% and return on capital employed (ROCE) at 42.2% significantly exceed typical sector averages, reflecting strong operational efficiency and capital utilization. The interest coverage ratio (ICR) is exceptionally high at 136,101.00x, indicating that the company has no debt, enabling it to withstand financial downturns without the burden of interest payments. However, the cash conversion cycle (CCC) of 147 days suggests a need for improvement in inventory and receivables management, as longer cycles can strain liquidity.
Balance Sheet Strength and Financial Ratios
Fluidomat Ltd’s balance sheet is characterized by a solid financial position, with total assets amounting to ₹93 Cr and total liabilities at ₹13 Cr, resulting in a debt-to-equity ratio of 0.00, indicating no reliance on external borrowings. The company’s reserves have increased to ₹80 Cr, reflecting retained earnings and a commitment to reinvest in growth. The price-to-book value (P/BV) ratio stands at 2.10x, which, while slightly above the sector average, suggests that investors are willing to pay a premium for the company’s strong growth prospects. Additionally, the current ratio of 2.74x indicates a healthy liquidity position, suggesting that Fluidomat can comfortably meet its short-term obligations. However, the inventory turnover ratio of 3.10x, while improved, remains a point of scrutiny, as optimizing inventory can further enhance financial efficiency.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Fluidomat Ltd reveals a stable ownership structure, with promoters holding 53.45% of the shares, which indicates strong management control and alignment with shareholder interests. The public holds 45.98%, while foreign institutional investors (FIIs) have a marginal stake of 0.58%. The increase in the number of shareholders from 5,122 in March 2023 to 10,018 by September 2025 demonstrates growing investor confidence and interest in the company. This expansion in the shareholder base can be attributed to the company’s consistent performance and solid fundamentals. However, the low FIIs participation could suggest a lack of international interest, which may limit capital inflow and broader market visibility. Enhancing communication with potential foreign investors could be beneficial for the company’s growth and market perception.
Outlook, Risks, and Final Insight
Looking ahead, Fluidomat Ltd is positioned for continued growth, driven by its robust financial metrics and a solid market presence. However, potential risks include supply chain disruptions and market volatility, which could impact revenue generation and profitability. The company must also address its cash conversion cycle to ensure liquidity remains strong. If Fluidomat successfully optimizes its operational efficiency and expands its market reach, particularly in international markets, it could enhance its revenue base significantly. Conversely, challenges such as competitive pressures and economic downturns could affect performance. In conclusion, while Fluidomat Ltd shows promising growth potential, maintaining operational efficiency and expanding shareholder engagement will be critical to navigating future challenges and capitalizing on opportunities in the engineering sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| KPT Industries Ltd | 198 Cr. | 583 | 1,028/540 | 15.8 | 218 | 0.51 % | 25.5 % | 22.5 % | 5.00 |
| Miven Machine Tools Ltd | 24.9 Cr. | 83.0 | 112/58.9 | 19.4 | 0.00 % | % | % | 10.0 | |
| Incon Engineers Ltd | 5.86 Cr. | 13.5 | 16.4/9.31 | 1.25 | 0.00 % | 64.2 % | % | 10.0 | |
| Hittco Tools Ltd | 7.21 Cr. | 11.7 | 16.0/10.3 | 4.68 | 0.00 % | 3.21 % | 0.29 % | 10.0 | |
| Harshil Agrotech Ltd | 42.0 Cr. | 0.45 | 5.98/0.40 | 5.05 | 1.27 | 0.00 % | 17.4 % | 16.4 % | 1.00 |
| Industry Average | 3,543.67 Cr | 446.78 | 35.69 | 119.01 | 0.32% | 37.74% | 16.87% | 6.04 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 13.03 | 9.92 | 14.29 | 12.56 | 14.65 | 12.63 | 15.65 | 15.59 | 19.00 | 16.64 | 20.95 | 12.39 | 16.40 |
| Expenses | 9.15 | 7.83 | 9.84 | 9.19 | 10.44 | 9.53 | 11.45 | 10.39 | 11.32 | 10.64 | 12.55 | 9.31 | 11.36 |
| Operating Profit | 3.88 | 2.09 | 4.45 | 3.37 | 4.21 | 3.10 | 4.20 | 5.20 | 7.68 | 6.00 | 8.40 | 3.08 | 5.04 |
| OPM % | 29.78% | 21.07% | 31.14% | 26.83% | 28.74% | 24.54% | 26.84% | 33.35% | 40.42% | 36.06% | 40.10% | 24.86% | 30.73% |
| Other Income | 0.39 | 0.36 | 0.17 | 0.59 | 0.70 | 0.58 | 1.58 | 0.67 | 0.76 | 1.33 | 0.70 | 0.79 | 1.63 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.20 | 0.20 | 0.14 | 0.19 | 0.19 | 0.18 | 0.20 | 0.21 | 0.23 | 0.23 | 0.27 | 0.29 | 0.31 |
| Profit before tax | 4.07 | 2.25 | 4.48 | 3.77 | 4.72 | 3.50 | 5.58 | 5.66 | 8.21 | 7.10 | 8.83 | 3.58 | 6.36 |
| Tax % | 25.06% | 24.00% | 26.34% | 26.53% | 25.21% | 25.43% | 25.63% | 25.09% | 24.73% | 23.66% | 27.63% | 25.14% | 24.06% |
| Net Profit | 3.05 | 1.71 | 3.30 | 2.77 | 3.52 | 2.61 | 4.15 | 4.24 | 6.17 | 5.42 | 6.39 | 2.68 | 4.84 |
| EPS in Rs | 6.19 | 3.47 | 6.70 | 5.62 | 7.14 | 5.30 | 8.42 | 8.61 | 12.52 | 11.00 | 12.97 | 5.44 | 9.82 |
Last Updated: December 26, 2025, 11:38 pm
Below is a detailed analysis of the quarterly data for Fluidomat Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 16.40 Cr.. The value appears strong and on an upward trend. It has increased from 12.39 Cr. (Jun 2025) to 16.40 Cr., marking an increase of 4.01 Cr..
- For Expenses, as of Sep 2025, the value is 11.36 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9.31 Cr. (Jun 2025) to 11.36 Cr., marking an increase of 2.05 Cr..
- For Operating Profit, as of Sep 2025, the value is 5.04 Cr.. The value appears strong and on an upward trend. It has increased from 3.08 Cr. (Jun 2025) to 5.04 Cr., marking an increase of 1.96 Cr..
- For OPM %, as of Sep 2025, the value is 30.73%. The value appears strong and on an upward trend. It has increased from 24.86% (Jun 2025) to 30.73%, marking an increase of 5.87%.
- For Other Income, as of Sep 2025, the value is 1.63 Cr.. The value appears strong and on an upward trend. It has increased from 0.79 Cr. (Jun 2025) to 1.63 Cr., marking an increase of 0.84 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2025, the value is 0.31 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.29 Cr. (Jun 2025) to 0.31 Cr., marking an increase of 0.02 Cr..
- For Profit before tax, as of Sep 2025, the value is 6.36 Cr.. The value appears strong and on an upward trend. It has increased from 3.58 Cr. (Jun 2025) to 6.36 Cr., marking an increase of 2.78 Cr..
- For Tax %, as of Sep 2025, the value is 24.06%. The value appears to be improving (decreasing) as expected. It has decreased from 25.14% (Jun 2025) to 24.06%, marking a decrease of 1.08%.
- For Net Profit, as of Sep 2025, the value is 4.84 Cr.. The value appears strong and on an upward trend. It has increased from 2.68 Cr. (Jun 2025) to 4.84 Cr., marking an increase of 2.16 Cr..
- For EPS in Rs, as of Sep 2025, the value is 9.82. The value appears strong and on an upward trend. It has increased from 5.44 (Jun 2025) to 9.82, marking an increase of 4.38.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:44 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 28 | 28 | 27 | 26 | 24 | 27 | 25 | 28 | 33 | 45 | 55 | 71 | 66 |
| Expenses | 20 | 20 | 21 | 22 | 21 | 24 | 22 | 23 | 26 | 33 | 40 | 43 | 44 |
| Operating Profit | 8 | 8 | 6 | 4 | 3 | 3 | 3 | 5 | 6 | 12 | 15 | 27 | 23 |
| OPM % | 30% | 28% | 21% | 15% | 12% | 11% | 13% | 17% | 19% | 27% | 27% | 39% | 34% |
| Other Income | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 3 | 3 | 4 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 8 | 8 | 6 | 4 | 3 | 3 | 4 | 5 | 7 | 13 | 18 | 30 | 26 |
| Tax % | 33% | 33% | 33% | 34% | 26% | 28% | 25% | 26% | 26% | 25% | 26% | 25% | |
| Net Profit | 6 | 5 | 4 | 3 | 2 | 2 | 3 | 4 | 5 | 10 | 13 | 22 | 19 |
| EPS in Rs | 11.57 | 10.82 | 8.06 | 5.58 | 4.73 | 4.85 | 6.49 | 8.08 | 11.14 | 19.53 | 26.49 | 45.10 | 39.23 |
| Dividend Payout % | 24% | 25% | 31% | 31% | 37% | 41% | 35% | 40% | 31% | 23% | 17% | 17% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -16.67% | -20.00% | -25.00% | -33.33% | 0.00% | 50.00% | 33.33% | 25.00% | 100.00% | 30.00% | 69.23% |
| Change in YoY Net Profit Growth (%) | 0.00% | -3.33% | -5.00% | -8.33% | 33.33% | 50.00% | -16.67% | -8.33% | 75.00% | -70.00% | 39.23% |
Fluidomat Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 23% |
| 3 Years: | 29% |
| TTM: | 18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 47% |
| 3 Years: | 62% |
| TTM: | 42% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 59% |
| 3 Years: | 80% |
| 1 Year: | 35% |
| Return on Equity | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 22% |
| 3 Years: | 26% |
| Last Year: | 31% |
Last Updated: September 5, 2025, 3:30 pm
Balance Sheet
Last Updated: January 7, 2026, 5:27 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | 16 | 20 | 22 | 25 | 26 | 27 | 28 | 32 | 36 | 44 | 56 | 76 | 80 |
| Borrowings | 0 | 0 | -0 | 0 | -0 | -0 | 1 | -0 | -0 | -0 | -0 | -0 | -0 |
| Other Liabilities | 7 | 7 | 7 | 6 | 7 | 7 | 7 | 8 | 10 | 11 | 10 | 13 | 13 |
| Total Liabilities | 28 | 32 | 34 | 36 | 38 | 40 | 41 | 45 | 51 | 60 | 71 | 93 | 98 |
| Fixed Assets | 7 | 8 | 8 | 8 | 7 | 7 | 7 | 7 | 8 | 7 | 8 | 12 | 11 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 2 | 2 |
| Investments | -0 | -0 | -0 | -0 | 1 | 1 | 1 | 1 | 1 | 3 | 5 | 8 | 12 |
| Other Assets | 21 | 24 | 26 | 28 | 29 | 32 | 33 | 37 | 41 | 50 | 58 | 71 | 73 |
| Total Assets | 28 | 32 | 34 | 36 | 38 | 40 | 41 | 45 | 51 | 60 | 71 | 93 | 98 |
Below is a detailed analysis of the balance sheet data for Fluidomat Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 5.00 Cr..
- For Reserves, as of Sep 2025, the value is 80.00 Cr.. The value appears strong and on an upward trend. It has increased from 76.00 Cr. (Mar 2025) to 80.00 Cr., marking an increase of 4.00 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 13.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 98.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 93.00 Cr. (Mar 2025) to 98.00 Cr., marking an increase of 5.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 11.00 Cr.. The value appears to be declining and may need further review. It has decreased from 12.00 Cr. (Mar 2025) to 11.00 Cr., marking a decrease of 1.00 Cr..
- For CWIP, as of Sep 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
- For Investments, as of Sep 2025, the value is 12.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2025) to 12.00 Cr., marking an increase of 4.00 Cr..
- For Other Assets, as of Sep 2025, the value is 73.00 Cr.. The value appears strong and on an upward trend. It has increased from 71.00 Cr. (Mar 2025) to 73.00 Cr., marking an increase of 2.00 Cr..
- For Total Assets, as of Sep 2025, the value is 98.00 Cr.. The value appears strong and on an upward trend. It has increased from 93.00 Cr. (Mar 2025) to 98.00 Cr., marking an increase of 5.00 Cr..
Notably, the Reserves (80.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 8.00 | 8.00 | 6.00 | 4.00 | 3.00 | 3.00 | 2.00 | 5.00 | 6.00 | 12.00 | 15.00 | 27.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 88 | 103 | 164 | 122 | 160 | 139 | 118 | 117 | 120 | 110 | 90 | 116 |
| Inventory Days | 155 | 212 | 223 | 165 | 181 | 142 | 214 | 189 | 141 | 141 | 113 | 84 |
| Days Payable | 72 | 89 | 75 | 58 | 92 | 79 | 118 | 123 | 137 | 91 | 70 | 53 |
| Cash Conversion Cycle | 170 | 225 | 312 | 228 | 249 | 202 | 214 | 183 | 124 | 159 | 132 | 147 |
| Working Capital Days | 64 | 94 | 164 | 133 | 185 | 169 | 171 | 159 | 146 | 90 | 150 | 155 |
| ROCE % | 45% | 35% | 23% | 15% | 10% | 11% | 13% | 15% | 18% | 29% | 32% | 42% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 19.48 | 11.65 | 8.93 | 6.05 |
| Diluted EPS (Rs.) | 19.48 | 11.65 | 8.93 | 6.05 |
| Cash EPS (Rs.) | 21.01 | 12.47 | 9.39 | 7.82 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 99.84 | 83.86 | 75.45 | 66.52 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 99.84 | 83.86 | 75.45 | 66.52 |
| Revenue From Operations / Share (Rs.) | 93.68 | 69.15 | 57.38 | 51.74 |
| PBDIT / Share (Rs.) | 27.62 | 15.73 | 12.30 | 10.01 |
| PBIT / Share (Rs.) | 26.12 | 14.38 | 11.00 | 8.66 |
| PBT / Share (Rs.) | 26.12 | 15.05 | 10.95 | 8.65 |
| Net Profit / Share (Rs.) | 19.51 | 11.12 | 8.09 | 6.47 |
| NP After MI And SOA / Share (Rs.) | 19.51 | 11.12 | 8.09 | 6.47 |
| PBDIT Margin (%) | 29.48 | 22.75 | 21.43 | 19.33 |
| PBIT Margin (%) | 27.88 | 20.79 | 19.16 | 16.74 |
| PBT Margin (%) | 27.88 | 21.76 | 19.08 | 16.72 |
| Net Profit Margin (%) | 20.82 | 16.07 | 14.09 | 12.51 |
| NP After MI And SOA Margin (%) | 20.82 | 16.07 | 14.09 | 12.51 |
| Return on Networth / Equity (%) | 19.53 | 13.25 | 10.72 | 9.73 |
| Return on Capital Employeed (%) | 25.54 | 16.69 | 14.21 | 12.66 |
| Return On Assets (%) | 16.03 | 10.69 | 8.87 | 7.77 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.02 |
| Asset Turnover Ratio (%) | 0.83 | 0.70 | 0.65 | 0.00 |
| Current Ratio (X) | 2.74 | 2.86 | 3.06 | 2.79 |
| Quick Ratio (X) | 2.07 | 2.32 | 2.25 | 2.05 |
| Inventory Turnover Ratio (X) | 3.10 | 2.36 | 1.90 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 17.94 | 29.23 | 0.00 | 30.88 |
| Dividend Payout Ratio (CP) (%) | 16.66 | 26.05 | 0.00 | 25.59 |
| Earning Retention Ratio (%) | 82.06 | 70.77 | 0.00 | 69.12 |
| Cash Earning Retention Ratio (%) | 83.34 | 73.95 | 0.00 | 74.41 |
| Interest Coverage Ratio (X) | 136101.00 | 2500.90 | 268.10 | 704.26 |
| Interest Coverage Ratio (Post Tax) (X) | 96208.00 | 1660.16 | 177.38 | 456.79 |
| Enterprise Value (Cr.) | 101.07 | 84.85 | 41.93 | 31.44 |
| EV / Net Operating Revenue (X) | 2.19 | 2.49 | 1.48 | 1.23 |
| EV / EBITDA (X) | 7.43 | 10.94 | 6.92 | 6.38 |
| MarketCap / Net Operating Revenue (X) | 2.24 | 2.55 | 1.52 | 1.23 |
| Retention Ratios (%) | 82.05 | 70.76 | 0.00 | 69.11 |
| Price / BV (X) | 2.10 | 2.10 | 1.15 | 0.95 |
| Price / Net Operating Revenue (X) | 2.24 | 2.55 | 1.52 | 1.23 |
| EarningsYield | 0.09 | 0.06 | 0.09 | 0.10 |
After reviewing the key financial ratios for Fluidomat Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 23, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 22) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 23, the value is 19.48. This value is within the healthy range. It has increased from 11.65 (Mar 22) to 19.48, marking an increase of 7.83.
- For Diluted EPS (Rs.), as of Mar 23, the value is 19.48. This value is within the healthy range. It has increased from 11.65 (Mar 22) to 19.48, marking an increase of 7.83.
- For Cash EPS (Rs.), as of Mar 23, the value is 21.01. This value is within the healthy range. It has increased from 12.47 (Mar 22) to 21.01, marking an increase of 8.54.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 23, the value is 99.84. It has increased from 83.86 (Mar 22) to 99.84, marking an increase of 15.98.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 23, the value is 99.84. It has increased from 83.86 (Mar 22) to 99.84, marking an increase of 15.98.
- For Revenue From Operations / Share (Rs.), as of Mar 23, the value is 93.68. It has increased from 69.15 (Mar 22) to 93.68, marking an increase of 24.53.
- For PBDIT / Share (Rs.), as of Mar 23, the value is 27.62. This value is within the healthy range. It has increased from 15.73 (Mar 22) to 27.62, marking an increase of 11.89.
- For PBIT / Share (Rs.), as of Mar 23, the value is 26.12. This value is within the healthy range. It has increased from 14.38 (Mar 22) to 26.12, marking an increase of 11.74.
- For PBT / Share (Rs.), as of Mar 23, the value is 26.12. This value is within the healthy range. It has increased from 15.05 (Mar 22) to 26.12, marking an increase of 11.07.
- For Net Profit / Share (Rs.), as of Mar 23, the value is 19.51. This value is within the healthy range. It has increased from 11.12 (Mar 22) to 19.51, marking an increase of 8.39.
- For NP After MI And SOA / Share (Rs.), as of Mar 23, the value is 19.51. This value is within the healthy range. It has increased from 11.12 (Mar 22) to 19.51, marking an increase of 8.39.
- For PBDIT Margin (%), as of Mar 23, the value is 29.48. This value is within the healthy range. It has increased from 22.75 (Mar 22) to 29.48, marking an increase of 6.73.
- For PBIT Margin (%), as of Mar 23, the value is 27.88. This value exceeds the healthy maximum of 20. It has increased from 20.79 (Mar 22) to 27.88, marking an increase of 7.09.
- For PBT Margin (%), as of Mar 23, the value is 27.88. This value is within the healthy range. It has increased from 21.76 (Mar 22) to 27.88, marking an increase of 6.12.
- For Net Profit Margin (%), as of Mar 23, the value is 20.82. This value exceeds the healthy maximum of 10. It has increased from 16.07 (Mar 22) to 20.82, marking an increase of 4.75.
- For NP After MI And SOA Margin (%), as of Mar 23, the value is 20.82. This value exceeds the healthy maximum of 20. It has increased from 16.07 (Mar 22) to 20.82, marking an increase of 4.75.
- For Return on Networth / Equity (%), as of Mar 23, the value is 19.53. This value is within the healthy range. It has increased from 13.25 (Mar 22) to 19.53, marking an increase of 6.28.
- For Return on Capital Employeed (%), as of Mar 23, the value is 25.54. This value is within the healthy range. It has increased from 16.69 (Mar 22) to 25.54, marking an increase of 8.85.
- For Return On Assets (%), as of Mar 23, the value is 16.03. This value is within the healthy range. It has increased from 10.69 (Mar 22) to 16.03, marking an increase of 5.34.
- For Total Debt / Equity (X), as of Mar 23, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 22) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 23, the value is 0.83. It has increased from 0.70 (Mar 22) to 0.83, marking an increase of 0.13.
- For Current Ratio (X), as of Mar 23, the value is 2.74. This value is within the healthy range. It has decreased from 2.86 (Mar 22) to 2.74, marking a decrease of 0.12.
- For Quick Ratio (X), as of Mar 23, the value is 2.07. This value exceeds the healthy maximum of 2. It has decreased from 2.32 (Mar 22) to 2.07, marking a decrease of 0.25.
- For Inventory Turnover Ratio (X), as of Mar 23, the value is 3.10. This value is below the healthy minimum of 4. It has increased from 2.36 (Mar 22) to 3.10, marking an increase of 0.74.
- For Dividend Payout Ratio (NP) (%), as of Mar 23, the value is 17.94. This value is below the healthy minimum of 20. It has decreased from 29.23 (Mar 22) to 17.94, marking a decrease of 11.29.
- For Dividend Payout Ratio (CP) (%), as of Mar 23, the value is 16.66. This value is below the healthy minimum of 20. It has decreased from 26.05 (Mar 22) to 16.66, marking a decrease of 9.39.
- For Earning Retention Ratio (%), as of Mar 23, the value is 82.06. This value exceeds the healthy maximum of 70. It has increased from 70.77 (Mar 22) to 82.06, marking an increase of 11.29.
- For Cash Earning Retention Ratio (%), as of Mar 23, the value is 83.34. This value exceeds the healthy maximum of 70. It has increased from 73.95 (Mar 22) to 83.34, marking an increase of 9.39.
- For Interest Coverage Ratio (X), as of Mar 23, the value is 136,101.00. This value is within the healthy range. It has increased from 2,500.90 (Mar 22) to 136,101.00, marking an increase of 133,600.10.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 23, the value is 96,208.00. This value is within the healthy range. It has increased from 1,660.16 (Mar 22) to 96,208.00, marking an increase of 94,547.84.
- For Enterprise Value (Cr.), as of Mar 23, the value is 101.07. It has increased from 84.85 (Mar 22) to 101.07, marking an increase of 16.22.
- For EV / Net Operating Revenue (X), as of Mar 23, the value is 2.19. This value is within the healthy range. It has decreased from 2.49 (Mar 22) to 2.19, marking a decrease of 0.30.
- For EV / EBITDA (X), as of Mar 23, the value is 7.43. This value is within the healthy range. It has decreased from 10.94 (Mar 22) to 7.43, marking a decrease of 3.51.
- For MarketCap / Net Operating Revenue (X), as of Mar 23, the value is 2.24. This value is within the healthy range. It has decreased from 2.55 (Mar 22) to 2.24, marking a decrease of 0.31.
- For Retention Ratios (%), as of Mar 23, the value is 82.05. This value exceeds the healthy maximum of 70. It has increased from 70.76 (Mar 22) to 82.05, marking an increase of 11.29.
- For Price / BV (X), as of Mar 23, the value is 2.10. This value is within the healthy range. There is no change compared to the previous period (Mar 22) which recorded 2.10.
- For Price / Net Operating Revenue (X), as of Mar 23, the value is 2.24. This value is within the healthy range. It has decreased from 2.55 (Mar 22) to 2.24, marking a decrease of 0.31.
- For EarningsYield, as of Mar 23, the value is 0.09. This value is below the healthy minimum of 5. It has increased from 0.06 (Mar 22) to 0.09, marking an increase of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Fluidomat Ltd:
- Net Profit Margin: 20.82%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 25.54% (Industry Average ROCE: 37.74%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 19.53% (Industry Average ROE: 16.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 96208
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.07
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 16.9 (Industry average Stock P/E: 35.69)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 20.82%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Engineering - General | 117, 1st Floor, Navneet Darshan, Indore Madhya Pradesh 452018 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ashok Jain | Chairman & Managing Director |
| Mrs. Radhica Sharma | Deputy Managing Director |
| Mr. Kunal Jain | Executive Director |
| Mr. Ashok Kumar Patni | Independent Director |
| Mr. Sharad Panot | Independent Director |
| Mr. Samyak Modi | Independent Director |
FAQ
What is the intrinsic value of Fluidomat Ltd?
Fluidomat Ltd's intrinsic value (as of 22 January 2026) is ₹955.38 which is 44.10% higher the current market price of ₹663.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹327 Cr. market cap, FY2025-2026 high/low of ₹1,419/617, reserves of ₹80 Cr, and liabilities of ₹98 Cr.
What is the Market Cap of Fluidomat Ltd?
The Market Cap of Fluidomat Ltd is 327 Cr..
What is the current Stock Price of Fluidomat Ltd as on 22 January 2026?
The current stock price of Fluidomat Ltd as on 22 January 2026 is ₹663.
What is the High / Low of Fluidomat Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Fluidomat Ltd stocks is ₹1,419/617.
What is the Stock P/E of Fluidomat Ltd?
The Stock P/E of Fluidomat Ltd is 16.9.
What is the Book Value of Fluidomat Ltd?
The Book Value of Fluidomat Ltd is 173.
What is the Dividend Yield of Fluidomat Ltd?
The Dividend Yield of Fluidomat Ltd is 1.13 %.
What is the ROCE of Fluidomat Ltd?
The ROCE of Fluidomat Ltd is 42.2 %.
What is the ROE of Fluidomat Ltd?
The ROE of Fluidomat Ltd is 31.4 %.
What is the Face Value of Fluidomat Ltd?
The Face Value of Fluidomat Ltd is 10.0.